Gilead Sciences
GILD
#134
Rank
โ‚น15.724 T
Marketcap
โ‚น12,682
Share price
1.80%
Change (1 day)
21.15%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): โ‚น663.49

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น706.38. In 2025 the company made an earnings per share (EPS) of โ‚น652.12 an increase over its 2024 EPS that were of โ‚น36.18.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น663.491.74%
2025โ‚น652.121702.63%
2024โ‚น36.18-91.65%
2023โ‚น433.1623.98%
2022โ‚น349.38-25.86%
2021โ‚น471.244850%
2020โ‚น9.52-97.64%
2019โ‚น403.650.9%
2018โ‚น400.0618.71%
2017โ‚น337.01-64.88%
2016โ‚น959.62-18.45%
2015โ‚น1,17755.28%
2014โ‚น757.79296.02%
2013โ‚น191.3517.89%
2012โ‚น162.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น831.54 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น124.71-82.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น195.81-72.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,687 280.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,378 95.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น890.12 26.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น526.46-25.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,619 129.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น340.33-51.82%๐Ÿ‡บ๐Ÿ‡ธ USA